| JXHL1100080 | ACT-293987 | selexipag | Active ingredient | Chemical Drugs | Import Drug Application | 2011-04-07 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | Certificate Issued | 2011-12-22 | view |
| JXHL1100069 | ACT-293987 | selexipag | Active ingredient | Chemical Drugs | Import Drug Application | 2011-04-02 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | Certificate Issued | 2011-12-22 | view |
| JXSL1100023 | ADI-PEG 20 | pegargiminase | Other | Biological Products | Import Drug Application | 2011-05-26 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | Certificate Issued | 2013-08-22 | view |
| JXHL1800096 | Aprocitentan片 | aprocitentan | Tablet | Chemical Drugs(1) | Import Drug Application | 2018-08-15 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | In Review | 2018-08-14 | view |
| JXHL1800097 | Aprocitentan片 | aprocitentan | Tablet | Chemical Drugs(1) | Import Drug Application | 2018-08-15 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | In Review | 2018-08-14 | view |
| JXHL1700210 | Ataluren口服混悬液颗粒 | ataluren | Granule | Chemical Drugs(5.1) | Import Drug Application | 2017-11-10 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | Certificate Issued | 2018-04-19 | view |
| JYHB1901425 | Ataluren口服混悬液颗粒 | ataluren | Granule | Chemical Drugs(5.1) | Supplementary Application | 2019-12-05 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | In Review | 2019-12-04 | view |
| JXHL1700212 | Ataluren口服混悬液颗粒 | ataluren | Granule | Chemical Drugs(5.1) | Import Drug Application | 2017-11-10 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | Certificate Issued | 2018-04-19 | view |
| JYHB1901424 | Ataluren口服混悬液颗粒 | ataluren | Granule | Chemical Drugs(5.1) | Supplementary Application | 2019-12-05 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | In Review | 2019-12-04 | view |
| JXHL1700211 | Ataluren口服混悬液颗粒 | ataluren | Granule | Chemical Drugs(5.1) | Import Drug Application | 2017-11-10 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | Certificate Issued | 2018-04-19 | view |
| JYHB1901426 | Ataluren口服混悬液颗粒 | ataluren | Granule | Chemical Drugs(5.1) | Supplementary Application | 2019-12-05 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | In Review | 2019-12-04 | view |
| JXSL1200026 | BIIB023 | BIIB023 | Other | Biological Products | Import Drug Application | 2012-04-19 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | Certificate Issued | 2013-11-25 | view |
| JXHL1900090 | Cenerimod片 | cenerimod | Tablet | Chemical Drugs(1) | Import Drug Application | 2019-05-08 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | In Review | 2019-05-07 | view |
| JXHL1900089 | Cenerimod片 | cenerimod | Tablet | Chemical Drugs(1) | Import Drug Application | 2019-05-08 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | In Review | 2019-05-07 | view |
| JXHL1900088 | Cenerimod片 | cenerimod | Tablet | Chemical Drugs(1) | Import Drug Application | 2019-05-08 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | In Review | 2019-05-07 | view |
| JXHL1900091 | Cenerimod片 | cenerimod | Tablet | Chemical Drugs(1) | Import Drug Application | 2019-05-08 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | In Review | 2019-05-07 | view |
| JXSL1800003 | FPA144注射液 | bemarituzumab | Injection | Biological Products | Import Drug Application | 2018-02-06 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | Certificate Issued | 2018-06-04 | view |
| JXSL1800004 | Inebilizumab注射液 | inebilizumab | Injection | Biological Products | Import Drug Application | 2018-02-11 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | Certificate Issued | 2018-06-29 | view |
| JXSS2000042 | Inebilizumab注射液 | inebilizumab | Injection | Biological Products(3.1) | Import Drug Application | 2020-10-14 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | In Review | 2020-10-12 | view |
| JXSS2000043 | Inebilizumab注射液 | inebilizumab | Injection | Biological Products(3.1) | Import Drug Application | 2020-10-14 | 杭州泰格医药科技股份有限公司 | Hangzhou Tigermed Consulting Co Ltd | In Review | 2020-10-12 | view |
